S. Poole

发表

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol

Ahalya K. Malachira, T. Clark, Kate R. Beard, 2019, BMJ Open.

Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

K. Saeed, S. Poole, Kiran Dadhwal, 2022, The clinical respiratory journal.

Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study

T. Clark, L. Presland, Vasanth V. Naidu, 2022, Infectious Diseases and Therapy.

Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19

D. Baralle, James P R Schofield, Fabio Strazzeri, 2022, Frontiers in Immunology.

Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19

D. Baralle, James P R Schofield, Fabio Strazzeri, 2022, Frontiers in Immunology.

Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: results of a randomised controlled trial.

F. Borca, T. Clark, M. Grocott, 2022, The Journal of infection.

Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

Ahilanandan Dushianthan, K. Saeed, S. Poole, 2021, The clinical respiratory journal.

Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department

J. Legramante, C. Tascini, S. Angeletti, 2021, Expert review of molecular diagnostics.

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study

S. Ewings, F. Borca, S. Kidd, 2020, The Lancet Respiratory Medicine.

Report of the Joint Nomenclature and Standardization Committee of the International Society of Hypertension, American Heart Association and the World Health Organization

J. Ménard, D. Ganten, M. Cantin, 1987, Journal of hypertension.

Rapid syndromic molecular testing in pneumonia: The current landscape and future potential

T. Clark, S. Poole, 2019, Journal of Infection.

Hot Topics in Diabetic Foot Infections.

Mohd Farhan, M. Bassetti, S. Unal, 2020, International journal of antimicrobial agents.

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus

T. Clark, N. Brendish, S. Poole, 2020, The Lancet Respiratory Medicine.

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study

T. Clark, N. Brendish, S. Poole, 2020, Journal of Infection.

A review of novel technologies and techniques associated with identification of bloodstream infection etiologies and rapid antimicrobial genotypic and quantitative phenotypic determination

S. Kidd, K. Saeed, S. Poole, 2018, Expert review of molecular diagnostics.

Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in blood.

D. Baralle, Fabio Strazzeri, P. Skipp, 2021, medRxiv.

Inflammatory phenotyping predicts clinical outcome in COVID-19

James Batchelor, C. Kipps, F. Borca, 2020, Respiratory Research.

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department

R. Crouch, F. Borca, M. Kiuber, 2022, Infection Control & Hospital Epidemiology.

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19

Tristan W. Clark, Sean Ewings, S. Ewings, 2020, Journal of Infection.

How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the International Society of Antimicrobial Chemotherapy (ISAC)

T. Welte, H. Wertheim, M. Plebani, 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection

F. Borca, T. Clark, L. Presland, 2020, Journal of Infection.

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

S. Ewings, Ahalya K. Malachira, T. Clark, 2020, The Lancet. Respiratory medicine.

A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

R. Eason, C. Sones, O. Quaye, 2021, Journal of Infection.

Re: 'Syndromic panels or “panel syndrome”? A perspective through the lens of respiratory-tract infections' by Zanella et al

T. Clark, N. Brendish, S. Poole, 2020, Clinical Microbiology and Infection.

SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death

F. Borca, H. Phan, Kate R. Beard, 2021, Journal of Infection.

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19

F. Borca, T. Clark, H. Lin, 2022, Journal of Infection.

Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19

M. G. Jones, B. Marshall, T. Clark, 2021, Respiratory Research.